Literature DB >> 3193008

Binding and blocking antibodies to the human acetylcholine receptor: are they selected in various myasthenia gravis forms?

E Morel1, B Vernet-der Garabedian, B Eymard, F Raimond, F A Bustarret, J F Bach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3193008     DOI： 10.1007/bf02918136

Source DB:  PubMed          Journal:  Immunol Res        ISSN： 0257-277X            Impact factor:   2.829


× No keyword cloud information.
  12 in total

Review 1.  Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert-Eaton syndrome.

Authors:  J Lindstrom
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

2.  Neonatal myasthenia gravis: a new clinical and immunologic appraisal on 30 cases.

Authors:  E Morel; B Eymard; B Vernet-der Garabedian; C Pannier; O Dulac; J F Bach
Journal:  Neurology       Date:  1988-01       Impact factor: 9.910

Review 3.  Humoral pathogenesis of myasthenia gravis.

Authors:  D B Drachman; S de Silva; D Ramsay; A Pestronk
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

4.  Antibody heterogeneity and specificity in myasthenia gravis.

Authors:  A Vincent; P J Whiting; M Schluep; F Heidenreich; B Lang; A Roberts; N Willcox; J Newsom-Davis
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

5.  Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis.

Authors:  D A Compston; A Vincent; J Newsom-Davis; J R Batchelor
Journal:  Brain       Date:  1980-09       Impact factor: 13.501

6.  [Heterogeneity of antibodies blocking the binding of bungarotoxin to the acetylcholine receptor in myasthenia].

Authors:  B Vernet-der-Garabédian; E Morel; J F Bach
Journal:  C R Acad Sci III       Date:  1984

7.  [Assay of acetylcholine receptor antibodies in myasthenia gravis. A study of 329 sera (author's transl)].

Authors:  E Morel; F Raimond; C Goulon-Goëau; S Berrih; B Vernet-Der-Garabedian; J Harb; J F Bach
Journal:  Nouv Presse Med       Date:  1982-05-22

8.  Increased binding of anti-acetylcholine receptor antibodies to thymic antigen in patients with myasthenia gravis and other autoimmune diseases, as compared to those with myasthenia gravis alone.

Authors:  E Morel; F Raimond; J F Bach
Journal:  J Neuroimmunol       Date:  1987-03       Impact factor: 3.478

9.  Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles.

Authors:  A Vincent; J Newsom-Davis
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

10.  Heterogeneity of antibodies directed against the alpha-bungarotoxin binding site on human acetylcholine receptor and severity of myasthenia gravis.

Authors:  B Vernet-der Garabedian; E Morel; J F Bach
Journal:  J Neuroimmunol       Date:  1986-07       Impact factor: 3.478
View more
  2 in total

1.  Decrease in the carbamylcholine-induced chemotaxis of monocytes in myasthenia gravis.

Authors:  S Sipka; P Diószeghy; F Mechler; K Lukács; J Szelényi; G Szegedi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

Review 2.  The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.

Authors:  S J Tzartos; M T Cung; P Demange; H Loutrari; A Mamalaki; M Marraud; I Papadouli; C Sakarellos; V Tsikaris
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.